Literature DB >> 26559569

The Path to Cancer --Three Strikes and You're Out.

Bert Vogelstein1, Kenneth W Kinzler.   

Abstract

Focusing on driver-gene mutations and the pathways they control has rendered complex cancer-genome landscapes intelligible. In solid tumors of adults, alterations in as few as three driver genes appear to suffice for a cell to evolve into an advanced cancer.

Entities:  

Mesh：

Year:  2015        PMID： 26559569     DOI： 10.1056/NEJMp1508811

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


  93 in total

1.  Conquering Metastatic Breast Cancer.

Authors:  Nancy E Davidson
Journal:  J Oncol Pract       Date:  2016-01       Impact factor: 3.840

Review 2.  Big Bang Tumor Growth and Clonal Evolution.

Authors:  Ruping Sun; Zheng Hu; Christina Curtis
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 3.  The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing.

Authors:  Jérôme Alexandre Denis; Erell Guillerm; Florence Coulet; Annette K Larsen; Jean-Marc Lacorte
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

4.  GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump.

Authors:  Georg Schneditz; Joshua E Elias; Ester Pagano; M Zaeem Cader; Svetlana Saveljeva; Kathleen Long; Subhankar Mukhopadhyay; Maryam Arasteh; Trevor D Lawley; Gordon Dougan; Andrew Bassett; Tom H Karlsen; Arthur Kaser; Nicole C Kaneider
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

Review 5.  Oral Epithelial Dysplasia and Premalignancy.

Authors:  Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2019-03-18

6.  Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.

Authors:  Belinda B Guo; Richard J Allcock; Bob Mirzai; Jacques A Malherbe; Fizzah A Choudry; Mattia Frontini; Hun Chuah; James Liang; Simon E Kavanagh; Rebecca Howman; Willem H Ouwehand; Kathryn A Fuller; Wendy N Erber
Journal:  Am J Pathol       Date:  2017-05-11       Impact factor: 4.307

Review 7.  Translating leukemia stem cells into the clinical setting: Harmonizing the heterogeneity.

Authors:  Breann Yanagisawa; Gabriel Ghiaur; B Douglas Smith; Richard J Jones
Journal:  Exp Hematol       Date:  2016-09-28       Impact factor: 3.084

Review 8.  Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank.

Authors:  Worta McCaskill-Stevens; Deborah C Pearson; Barnett S Kramer; Leslie G Ford; Scott M Lippman
Journal:  Cancer Prev Res (Phila)       Date:  2016-12-13

Review 9.  Pancreatic cancer biology and genetics from an evolutionary perspective.

Authors:  Alvin Makohon-Moore; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Cancer       Date:  2016-07-22       Impact factor: 60.716

10.  Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.

Authors:  Mrinal M Gounder; Alona Zer; William D Tap; Samer Salah; Mark A Dickson; Abha A Gupta; Mary Louise Keohan; Herbert H Loong; Sandra P D'Angelo; Stephanie Baker; Mercedes Condy; Kjirsten Nyquist-Schultz; Lanier Tanner; Joseph P Erinjeri; Francis H Jasmine; Sharon Friedlander; Robert Carlson; Thaddeus J Unger; Jean-Richard Saint-Martin; Tami Rashal; Joel Ellis; Michael Kauffman; Sharon Shacham; Gary K Schwartz; Albiruni Ryan Abdul Razak
Journal:  J Clin Oncol       Date:  2016-07-25       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.